The DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
Olanzapine therapy in anorexia nervosa: psychobiological effects
Open accessAbstract
Dopamine impairments occur in anorexia nervosa. The aim of this study was to see whether treatment with the atypical dopamine antagonist antipsychotic olanzapine improves the disorder. Thirty anorexics, 18 restricted and 12 bingeing-purging, underwent a 3-month course of cognitive behavioral therapy, plus at random and double-blinded oral olanzapine (2.5 mg for 1 month, 5 mg for 2 months) in half and oral placebo in the other half of them. BMI, psychopathological aspects (eating disorder inventory, Hamilton Rating Scale, Buss-Durkee Rating Scale, Yale Brown Cornell for Eating Disorders Rating Scale, temperament-character inventory), and homovanillic acid blood concentrations for dopamine secretion, were monitored at baseline and then monthly during the trial. At the end of the trial BMI, total eating disorder inventory, total Yale Brown Cornell for Eating Disorders Rating Scale, Buss-Durkee Rating Scale, Hamilton Rating Scale scores and in olanzapine-treated patients the subitems of eating disorder inventory ineffectiveness and maturity fear, of Buss-Durkee Rating Scale direct aggressiveness, of temperament-characteristic inventory persistence had improved significantly. When stratified for anorexia nervosa subtype, BMI changes were significant among anorexia nervosa bingeing-purging patient, 'depression' (Hamilton Rating Scale) and 'direct aggressiveness' (Buss-Durkee Rating Scale) among anorexia nervosa bingeing-purging patients, 'persistence' (temprerament-characteristic inventory), among anorexics restricted patients, with a trend toward significance for obsessivity-compulsivity (Yale Brown Cornell for Eating Disorders Rating Scale). homovanilic acid blood levels increased significantly in the cognitive behavioral therapy+olanzapine group. No correlations were observed between homovanilic acid concentrations and psychopathological parameters. The pharmacological treatment can significantly improve specific aspects of anorexia nervosa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
An inventory for assessing different kinds of hostility.
Buss, A. H., & Durkee, A. (1957) · Journal of Consulting Psychology · doi:10.1037/h0046900 · Cited by 2,614
The temperament and character inventory (TCI) : a guide to its development and use
Cloninger, C. R. (1994) · Medical Entomology and Zoology · Cited by 2,319
Handbook of treatment for eating disorders
(1997) · Choice Reviews Online · doi:10.5860/choice.35-2151 · Cited by 1,074
Nyman‐Carlsson, E., & Garner, D. M. (2017) · Springer eBooks · doi:10.1007/978-981-287-104-6_192 · Cited by 595
Antipsychotic-induced weight gain: a review of the literature.
Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 594
Strober, M. A., Freeman, R., Lampert, C., Diamond, J., & Kaye, W. H. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.393 · Cited by 557
Amisulpride, an Unusual “Atypical” Antipsychotic: A Meta-Analysis of Randomized Controlled Trials
Leucht, S., Pitschel‐Walz, G., Engel, R. R., & Kissling, W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.180 · Cited by 470
Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism
Reynolds, G. P., Zhang, Z., & Zhang, X. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08913-4 · Cited by 413
Psychological therapies for adults with anorexia nervosa
Dare, C., Eisler, I., Russell, G. F. M., Treasure, J. L., & Dodge, L. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.3.216 · Cited by 378
Frank, G. K., Bailer, U. F., Henry, S. E., Drevets, W., Meltzer, C. C., Price, J. C., Mathis, C. A., Wagner, A., Hoge, J., Ziolko, S., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.003 · Cited by 361
Abnormalities in CNS Monoamine Metabolism in Anorexia Nervosa
Kaye, W. H. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790150040007 · Cited by 265
Cognitive Behavioral Therapy for Anorexia Nervosa
(2012) · PsycEXTRA Dataset · doi:10.1037/e675412012-001 · Cited by 217
The Yale-Brown-Cornell eating disorder scale: Development, use, reliability and validity
Mazure, C. M., Halmi, K. A., Sunday, S. R., Romano, S. J., & Einhorn, A. M. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90002-7 · Cited by 213
Altered Dopamine Activity after Recovery from Restricting-Type Anorexia Nervosa
Kaye, W. H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00053-6 · Cited by 194
Kaye, W. H., Gendall, K. A., & Strober, M. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00195-4 · Cited by 193
Management of child and adolescent eating disorders: the current evidence base and future directions
Gowers, S., & Bryant‐Waugh, R. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1046/j.0021-9630.2003.00309.x · Cited by 185
Pimozide combined with behavior therapy in the short‐term treatment of anorexia nervosa
Vandereycken, W., & Pierloot, R. A. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb04501.x · Cited by 175
In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.
Bymaster, F. P., Rasmussen, K. G., Calligaro, D. O., NELSON, D. A., DeLapp, N. W., Wong, D. T., & Moore, N. A. (1997) · PubMed · Cited by 162
Vandereycken, W. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.144.3.288 · Cited by 150
Olanzapine in the treatment of anorexia nervosa: An open label trial
Powers, P. S., Santana, C. A., & Bannon, Y. (2002) · International Journal of Eating Disorders · doi:10.1002/eat.10084 · Cited by 150
Treatment and outcome of anorexia nervosa.
Dally, P., & Sargant, W. (1966) · BMJ · doi:10.1136/bmj.2.5517.793 · Cited by 142
Randomized Controlled Trial of Olanzapine in the Treatment of Cognitions in Anorexia Nervosa
Mondraty, N., Laird Birmingham, C., Touyz, S., Sundakov, V., Chapman, L., & Beumont, P. (2005) · Australasian Psychiatry · doi:10.1080/j.1440-1665.2004.02154.x · Cited by 130
Kaye, W. H., Frank, G., Bailer, U. F., & Henry, S. E. (2005) · International Journal of Eating Disorders · doi:10.1002/eat.20109 · Cited by 129
An Open Trial of Olanzapine in Anorexia Nervosa
Barbarich, N. C., McConaha, C. W., Gaskill, J. A., Via, M. L., Frank, G., Achenbach, S., Plotnicov, K. H., & Kaye, W. H. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1106 · Cited by 103
Characterization of olanzapine-induced weight gain in rats
Goudie, A. J., Smith, J. A., & Halford, J. C. G. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600402 · Cited by 102
Boachie, A., Goldfield, G. S., & Spettigue, W. J. (2002) · International Journal of Eating Disorders · doi:10.1002/eat.10115 · Cited by 96
Cerebrospinal Fluid and Plasma Monoamine Metabolites and Their Relation to Psychosis
Pickar, D. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810190041006 · Cited by 96
Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases
Mehler, C., Wewetzer, C., Schulze, U., Warnke, A., Theisen, F., & Dittmann, R. (2001) · European Child & Adolescent Psychiatry · doi:10.1007/s007870170039 · Cited by 94
Efficacy of citalopram in anorexia nervosa: a pilot study
Fassino, S. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00058-5 · Cited by 87
Self-citationSex differences in clinical response to olanzapine compared with haloperidol
Goldstein, J. M., Cohen, L. S., Horton, N. J., Lee, H., Andersen, S. W., Tohen, M. F., Crawford, A. M., & Tollefson, G. D. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00028-8 · Cited by 86
Hillebrand, J. J., Elburg, A. A. V., Kas, M. J., van Engeland, H., & Adan, R. A. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.008 · Cited by 85
Olanzapine treatment of anorexia nervosa: A retrospective study
Malina, A., Gaskill, J. A., McConaha, C. W., Frank, G., LaVia, M., Scholar, L., & Kaye, W. H. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10122 · Cited by 80
Neurochemical abnormalities of anorexia nervosa and bulimia nervosa
D, M. F. M., Copeland, P. M., Schweiger, U., & Herzog, D. B. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.8.963 · Cited by 78
Ruggiero, G. M., Laini, V., Mauri, M. C., Ferrari, V. M. S., Clemente, A., Lugo, F., Mantero, M., Redaelli, G., Zappulli, D., & Cavagnini, F. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00174-9 · Cited by 76
Urwin, R., Bennetts, B., Wilcken, B. M., Lampropoulos, B., Beumont, P. J. V., Clarke, S., Russell, J. D., Tanner, S. L., & Nunn, K. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001080 · Cited by 76
The Psychobiology of Anorexia Nervosa
Pirke, K. M., & Ploog, D. W. (1984) · Springer eBooks · doi:10.1007/978-3-642-69594-0 · Cited by 64
RISPERIDONE IN ANOREXIA NERVOSA
Newman-Toker, J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200008000-00002 · Cited by 63
CSF neurochemistry of women with anorexia nervosa and normal women
Gerner, R. H., Cohen, D. J., Fairbanks, L. A., Anderson, G. M., Young, J. G., Scheinin, M., Linnoila, M., Shaywitz, B. A., & Hare, T. A. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1441 · Cited by 62
A review and primer of molecular genetic studies of anorexia nervosa
Klump, K. L., & Gobrogge, K. L. (2005) · International Journal of Eating Disorders · doi:10.1002/eat.20116 · Cited by 61
Cassano, G. B., Miniati, M., Pini, S., Rotondo, A., Banti, S., Borri, C., Camilleri, V., & Mauri, M. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10130 · Cited by 59
Sertraline in the Treatment of Restricting Anorexia Nervosa: An Open Controlled Trial
Santonastaso, P., Friederici, S., & Favaro, A. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750284045 · Cited by 55
Self-citationAnorexia nervosa: Treatment with olanzapine
Jensen, V. S., & Mejlhede, A. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.1.87 · Cited by 55
Olanzapine in the treatment of anorexia nervosa
Hansen, L. K. (1999) · The British Journal of Psychiatry · doi:10.1192/s000712500026354x · Cited by 53
Central dopaminergic function in Anorexia and Bulimia Nervosa: a psychoneuroendocrine approach
Brambilla, F. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00062-7 · Cited by 52
Self-citationLack of Association between Anorexia Nervosa and D3 Dopamine Receptor Gene
Bruins-Slot, L., Gorwood, P. A. P. M., Bouvard, M. P., Blot, P., Adès, J., Feingold, J., Schwartz, J., & Mouren, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00199-6 · Cited by 50
A Comparison of the Effects of Olanzapine and Risperidone Versus Placebo on Eating Behaviors
Roerig, J. L., Mitchell, J. E., de Zwaan, M., Crosby, R. D., Gosnell, B. A., Steffen, K. J., & Wonderlich, S. A. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000177549.36585.29 · Cited by 48
Drug Therapy for Patients with Eating Disorders
Mitchell, J. C., de Zwaan, M., & Roerig, J. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033338850 · Cited by 47
Castro, J., Deulofeu, R., Gila, A., Puig, J., & Toro, J. (2004) · International Journal of Eating Disorders · doi:10.1002/eat.10249 · Cited by 43
Glazer, W. M., Bowers, M. B., Charney, D. S., & Heninger, G. R. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90034-6 · Cited by 43
Towards the pharmacotherapy of eating disorders
Pederson, K. J., Roerig, J. L., & Mitchell, J. E. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.10.1659 · Cited by 38
Scheepers, F. E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00250-0 · Cited by 38
Bernardo, M., Parellada, E., Lomeña, F., Catafau, A. M., Font, M., Gómez, J. C., López-Carrero, C., Gutiérrez, F., Pavı́a, J., & Salamero, M. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00085-3 · Cited by 35
Impaired visual discrimination learning in anorexia nervosa
Lawrence, A. D., Dowson, J. H., Foxall, G., Summerfield, R., Robbins, T. W., & Sahakian, B. J. (2003) · Appetite · doi:10.1016/s0195-6663(02)00138-1 · Cited by 34
Excretion of biogenic amine metabolites in anorexia nervosa
Riederer, P. F., Toifl, K., & Kruzik, P. (1982) · Clinica Chimica Acta · doi:10.1016/0009-8981(82)90109-7 · Cited by 32
Kaye, W. H. (1988) · Psychoneuroendocrinology · doi:10.1016/0306-4530(88)90024-8 · Cited by 30
Olanzapine treatment of an adolescent girl with anorexia nervosa
Ercan, E. S., Copkunol, H., Çýkoðlu, S., & Varan, A. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.492 · Cited by 28
Fava, G. A., Grandi, S., & CANESTRARI, R. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.813 · Cited by 26
Plasma homovanillic acid in untreated schizophrenia — relationship with symptomatology and sex
Zhang, Z. J., Peet, M., Ramchand, C. N., Shah, S., & Reynolds, G. P. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00008-5 · Cited by 24
Role of Fluoxetine in Anorexia Nervosa
Kim, S. S. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c362 · Cited by 20
Low dopamine and serotonin levels in anorexia nervosa
Gillberg, C. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.7.948c · Cited by 19
The psychobiology of eating behavior in anorexia nervosa
Halmi, K. A. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02986-1 · Cited by 18
Neurotransmitter Metabolism in Anorexia Nervosa
Ebert, M. H., Kaye, W., & Gold, P. W. (1984) · Springer eBooks · doi:10.1007/978-3-642-69594-0_7 · Cited by 16
Elevated plasma monoamine metabolites in eating disorders
Bowers, M. B., Mazure, C. M., & Greenfeld, D. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90115-5 · Cited by 16
van Binsbergen, C. J. M., Odink, J., van der Beek, E. J., Westenberg, H. G. M., & Bennink, H. J. T. C. (1991) · Psychosomatic Medicine · doi:10.1097/00006842-199107000-00009 · Cited by 15
Pharmacological Treatment of Eating Disorders
de Zwaan, M., & Roerig, J. L. (2003) · Eating Disorders · doi:10.1002/0470867183.ch4 · Cited by 12
Olanzapine in Anorexia Nervosa
Bosanac, P., Burrows, G. D., & Norman, T. R. (2003) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2003.01221.x · Cited by 12
Köhle, K., & Mall, H. (1983) · International Journal of Eating Disorders · doi:10.1002/1098-108x(198322)2:4 · Cited by 9
Clinical Considerations in Selecting and Using Atypical Antipsychotics
Newcomer, J. W. (2005) · CNS Spectrums · doi:10.1017/s1092852900025177 · Cited by 7
Halmi, K. A., & Sherman, B. S. (1977) · PubMed · Cited by 6
Use of Olanzapine in Anorexia Nervosa
Menaster, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0519a · Cited by 3
Psychological Interventions for Eating Disorders
Wilson, G. T. (2003) · Eating Disorders · doi:10.1002/0470867183.ch5 · Cited by 2
Olanzapine for the Treatment of Bipolar Disorder
Ahmed, S., Degenhardt, E. K., & McGuire, H. C. (2002) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v04n0307 · Cited by 1
Outcome of hospital-treated depression
Ridley-Siegert, D. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.1.86-a · Cited by 1
Research works printed but not linked: 13
- Allison, 2001, J Clin Psychiatry, 62, 22
- Backer, 2003, Biol Psychiatry, 53, 133S
- Bosanac, 2005, Aust N Z J Psychiatry, 37, 494
- Bymaster, 1997, J Clin Psychiatry, 58, 28
- Coates, 2000, Br J Psychiatry, 25, S92
- Gaskill, 2001, Int J Eat Disord Review, 12, 1
- Gillberg, 1983, Am J Psychiatry, 140, 948
- Halmi, 1977, Psychopharmacol Bull, 13, 63
- Klump, 2005, In J Eat Disord, 37, 541
- Lipkovich, 2004, Biol Psychiatry, 55, 181S
- Mangano, 2004, Ital J Psychopathology, 8, 249
- Odink, 1986, Bio Amines, 3, 257
- Owen, 1983, Psychopharmacol Bull, 19, 578
Cited by
Sorted by citations
Treasure, J. L., Claudino, A. M., & Zucker, N. L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61748-7 · Cited by 661
Identification and Management of Eating Disorders in Children and Adolescents
Rosen, D. S. (2010) · PEDIATRICS · doi:10.1542/peds.2010-2821 · Cited by 387
Watson, H. J., & Bulik, C. M. (2013) · Psychological Medicine · doi:10.1017/s0033291712002620 · Cited by 339
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Treasure, J. L., Zipfel, S., Micali, N., Wade, T. D., Stice, E. M., Claudino, A. M., Schmidt, U. H., Frank, G., Bulik, C. M., & Wentz, E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.74 · Cited by 302
Metadata
- Authors
- Brambilla, F., Garcia, C. S., Fassino, S., Daga, G. A., Favaro, A., Santonastaso, P., Ramaciotti, C., Bondi, E., Mellado, C., Borriello, R., & Monteleone, P.
- Affiliations
- University of Pisa (IT)
- Venue
- International Clinical Psychopharmacology
- Published
- 2007-07
- Volume
- 22
- Issue
- 4
- Pages
- 197-204
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2045510386
- Cited by
- 156
- References
- 78
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 8 · 2023: 9 · 2022: 2 · 2021: 4 · 2020: 7 · 2019: 10 · 2018: 6 · 2017: 5 · 2016: 1 · 2015: 12 · 2014: 7 · 2013: 9 · 2012: 10
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Nutrition, Health and Food Behavior
- Keywords
- anorexia nervosa, olanzapine, atypical antipsychotics, dopamine antagonists, homovanillic acid, cognitive behavioral therapy, eating disorder symptoms, temperament, aggression, depression, obsessive-compulsive symptoms
- MeSH terms
- Olanzapine, Adult, Anorexia Nervosa, Benzodiazepines, Combined Modality Therapy, Double-Blind Method, Female, Homovanillic Acid, Humans, Antipsychotic Agents, Cognitive Behavioral Therapy, Dopamine Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review